Total Funding
7
52
Total FundingVenture - Series Unknown raised
Growth Score 7 in past quarter
-9 pts
Heat Score 52 in past quarter
11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
689729
Molecular Vision, an optical detection company, offers a platform technology solution for versatile optical detection in a portable format.
Acquired by 

Abingdon Health
Chris Hand: CEOPast Role: Cozart Bioscience Ltd, Chief Executive
About the Company
Molecular Vision is an optical detection company that offers a platform technology solution for versatile optical detection in a portable format. It carries an integration of low-cost organic light emitting diodes and organic photodetectors with analytical devices. This enables the realization of hand-held disposable medical diagnostics devices for
point-of-care testing. Additional applications for the portable quantitative analytical devices include in-the-field veterinary testing, food and plant testing, environmental monitoring, and homeland security.
Molecular Vision was founded in 2001 and is based in London, United Kingdom.

